JPS62497A - Cyclic biphenyl ether compound and production thereof - Google Patents

Cyclic biphenyl ether compound and production thereof

Info

Publication number
JPS62497A
JPS62497A JP60137033A JP13703385A JPS62497A JP S62497 A JPS62497 A JP S62497A JP 60137033 A JP60137033 A JP 60137033A JP 13703385 A JP13703385 A JP 13703385A JP S62497 A JPS62497 A JP S62497A
Authority
JP
Japan
Prior art keywords
formula
compound
hydrogen
group
methanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP60137033A
Other languages
Japanese (ja)
Other versions
JPH0662670B2 (en
Inventor
Shosuke Yamamura
山村 庄亮
Shigeru Nishiyama
繁 西山
Kazuhiko Nakamura
和彦 中村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TOUBISHI YAKUHIN KOGYO KK
Tobishi Pharmaceutical Co Ltd
Original Assignee
TOUBISHI YAKUHIN KOGYO KK
Tobishi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TOUBISHI YAKUHIN KOGYO KK, Tobishi Pharmaceutical Co Ltd filed Critical TOUBISHI YAKUHIN KOGYO KK
Priority to JP60137033A priority Critical patent/JPH0662670B2/en
Publication of JPS62497A publication Critical patent/JPS62497A/en
Publication of JPH0662670B2 publication Critical patent/JPH0662670B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

NEW MATERIAL:A cyclic biphenyl ether compound shown by the formula I (R1 is H or formyl: R2 is H or methyl; R3 is H or acetyl; R4 is lower alkyl; R5 is H or methyl; X is H or Br). EXAMPLE:A compound shown by the formula II. USE:An intermediate for synthesizing a compound shown by the formula III (R is H or OH) showing antitumor activity. PREPARATION:A compound shown by the formula IV is catalytically reduced to give a compound shown by the formula V among compounds shown by the formula I. N-Protected N, O-dimethyltyrosine is combined with L-alanine methyl ester, the amino-protecting group is removed to combine the L-alanine, further the amino group is combined with D-alanine to produce tetrapeptide, which is combined with the amino group of the compound shown by the formula II and subjected to ring closure to give a compound shown by the formula III.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、薬効ある化合物の合成中間体として有用な新
規環状ビフェニルエーテル化合物及びその製造方法に関
する。
DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to a novel cyclic biphenyl ether compound useful as an intermediate for the synthesis of medicinal compounds and a method for producing the same.

〔従来の技術〕[Conventional technology]

従来、メΦシコ産の植物〔ブーパルシア テルニフオリ
ア(Bouvardia ternifolia))又
はアカネ草〔ルヒアアカネ(Rubia akane)
若しくはルビア コルディアフォリア(Rubia a
ordia−folia)  根より、下記一般式(1
):(式中Rは水素又は水酸基を示す)で表わされる化
合物が単離され、顕著な抗腫瘍活性を示すことが知られ
ている〔ジャーナル オプ ジアメリカン ケミカル 
ソサイティ(J、 Am、 Ohθm。
Traditionally, plants grown in Mexico (Bouvardia ternifolia) or madder grass (Rubia akane) were used.
Or Rubia cordiafolia (Rubia a
ordia-folia) From the root, the following general formula (1
): (wherein R represents hydrogen or hydroxyl group) has been isolated and is known to exhibit significant antitumor activity [Journal Op.
Society (J, Am, Ohθm.

Hoe、 ) 、ig 9 q巻第804Q頁(197
7)、ケミカル アンド ファーマシューテ力ル ビュ
レチ7 (C!hem、 Pharm、 Bull、 
) 第52巻第284頁(1984)参照〕。
Hoe, ), ig 9q, p. 804Q (197
7), Chemical and Pharmacy Bullech 7 (C!hem, Pharm, Bull,
) Vol. 52, p. 284 (1984)].

〔発明が解決しようとする問題点〕[Problem that the invention seeks to solve]

しかし、前記一般式(1)で表わされる化合物は、天然
物中には微量しか含まれておらず(例えば12kgよF
) 10 nip前後)、その利用は不便である。
However, the compound represented by the general formula (1) is only contained in trace amounts in natural products (for example, 12 kg
), its use is inconvenient.

本発明の目的は、前記一般式(1)で表わされる化合物
を合成化学的に得ることを最終目的とし、その合成中間
体となる新規化合物及びその製造方法を提供することに
ある。
An object of the present invention is to provide a novel compound that is a synthetic intermediate, with the ultimate objective of synthetically obtaining the compound represented by the general formula (1), and a method for producing the same.

〔問題点を解決するための手段〕[Means for solving problems]

本発明を概説すれば、本発明の第1の発明は新規な環状
ビフェニルエーテル化合物に関する発明であって、下記
一般式 (式中、烏は水素又はホルミル基、烏は水素又はメチル
基、馬は水素又はアセチル基、穐は低級アルキル基、烏
は水素又はメチル基、又は水素又は臭素を示す)で表わ
すれることを特徴とする。
To summarize the present invention, the first invention of the present invention relates to a novel cyclic biphenyl ether compound, which has the following general formula: It is characterized by being represented by hydrogen or an acetyl group, ``Akira'' represents a lower alkyl group, and ``Crow'' represents hydrogen or a methyl group, or hydrogen or bromine.

また本発明の第2の発明は、下記一般式(式中、烏は水
素又はホルミル基、烏は水素又はメチル基、馬は水素又
はアセチル基、曳は低級アルキル基、烏は水素又はメチ
ル基を示す)で表わされる環状ビフェニルエーテル化合
物の製造方法に関する発明であって、下記一般式(式中
、&〜凡は前記のとおりである)で表わされる化合物を
接触還元することを特徴とする。
The second invention of the present invention is based on the following general formula (where Karasu is hydrogen or formyl group, Karasu is hydrogen or methyl group, Uma is hydrogen or acetyl group, Hiki is lower alkyl group, Karasu is hydrogen or methyl group) This invention relates to a method for producing a cyclic biphenyl ether compound represented by the following general formula (in which & is as described above), which is characterized by catalytic reduction.

更に、本発明の第3の発明は、下記一般式(式中、&は
水素又はホルミル基、馬は水素又はメチル基、烏は水素
又はアセチル基、馬は低級アルキル基、鳥は水素又はメ
チル基を示すが、馬、馬及び馬のうち少なくとも1つは
水素以外の基を示す)で表わされる環状ビフェニルエー
テル化合物の製造方法に関する発明であって、下記一般
式 %式% (式中、人は前記のとおりである)で表わされる化合物
を、メタノール含有溶媒中、タリウム(l[[)塩で処
理して、下記一般式 (式中、曳は前記のとおりである)で表わされるジェノ
ン化合物を得、これを亜鉛還元して下記一般式 (式中、凡は前記のとおりである)で表わされる化合物
を得、これを接触還元し、次いでアセチル化及び/又は
メチル化し、更に所望によシ保膜基を除去することを特
徴とする。
Furthermore, the third invention of the present invention is based on the following general formula (where & is hydrogen or formyl group, horse is hydrogen or methyl group, crow is hydrogen or acetyl group, horse is lower alkyl group, bird is hydrogen or methyl group) The present invention relates to a method for producing a cyclic biphenyl ether compound represented by the following general formula % (wherein, is as described above) is treated with thallium (l[[) salt in a methanol-containing solvent to obtain a genone compound represented by the following general formula (wherein is as described above). This is zinc-reduced to obtain a compound represented by the following general formula (wherein the formulas are as described above), which is catalytically reduced, then acetylated and/or methylated, and further processed as desired. It is characterized by removing the membrane-retaining group.

しだがって、本発明の化合物の1例について、チロシン
からの製造方法を略記すれば以下のとおシである。
Therefore, the method for producing one example of the compound of the present invention from tyrosine is as follows.

(1)      CI’l’)          
(V)〔■〕        〔■〕 〔罰        〔■〕 以下、上記反応工程について説明する。
(1) CI'l')
(V) [■] [■] [Punishment [■]] The above reaction steps will be explained below.

化合物■はチロシンであシ、この反応の出発物質である
。この化合物■のアミノ基及びカルボキシル基を保護し
たのち臭素化しく化合物め、アミン又はカルボキシル保
護基を除去してアミド結合により化合物Vのテトラブロ
モ体を製造する。
Compound (1) is tyrosine, which is the starting material for this reaction. After protecting the amino group and carboxyl group of this compound (1), the compound is brominated, the amine or carboxyl protecting group is removed, and the tetrabromo form of compound V is produced by an amide bond.

このテトラブロモ体を、メタノール含有溶媒中、タリウ
ム(III)塩で処理して、メトキシジェノン体(化合
物■)を生成させる。これは本発明方法の1工程であり
、本発明方法のうち中心をなすものである。
This tetrabromo compound is treated with thallium (III) salt in a methanol-containing solvent to produce a methoxygenone compound (compound ①). This is one step of the method of the present invention, and is the center of the method of the present invention.

従来、タリウム(III)塩をフェノールの酸化的カッ
プリングに用いた例がわずかであるが知られている〔ア
トパンセス イン オーガノメタリツク ケミストリー
(Advanc、 Organomet、 Chem、
)第11巻第147頁(1973)参照〕。本発明方法
はそれを基にしている。■価のタリウム塩としては、酢
酸タリウム、トリフルオロ酢酸タリウム、過塩素酸タリ
ウム及び硝酸タリウム等が知られているが、本発明者等
は、これらの中で最もイオン性の高い硝酸タリウム(T
/(Non)l・5HaO)の3当量が、本発明方法に
おいて最適であることを見出した。また、メタノール含
有溶媒としては、溶解性の点からメタノール−ジメチル
ホルムアミド混合溶媒が最適であることも見出した。反
応は、生成物の分解、副生物の増加の点から40℃未満
がよ(、−25℃〜室温、好ましくは0℃、−晩の条件
がよい。
There are a few known examples of using thallium (III) salts for oxidative coupling of phenol [Advance, Organomet, Chem,
) Vol. 11, p. 147 (1973)]. The method of the invention is based thereon. As valent thallium salts, thallium acetate, thallium trifluoroacetate, thallium perchlorate, thallium nitrate, etc. are known, but the present inventors found that thallium nitrate (T
/(Non)l·5HaO) was found to be optimal in the method of the present invention. It has also been found that a methanol-dimethylformamide mixed solvent is most suitable as the methanol-containing solvent from the viewpoint of solubility. The reaction is preferably carried out at a temperature below 40°C, from the viewpoint of product decomposition and increase in by-products (-25°C to room temperature, preferably 0°C, overnight).

次に■を亜鉛還元して■を製造する。この工程は常法の
亜鉛還元であり、亜鉛末−酢酸による冷却下の反応でよ
い。
Next, ■ is reduced with zinc to produce ■. This step is a conventional method of zinc reduction, and may be a reaction under cooling with zinc dust and acetic acid.

次に、化合物■を接触還元して■を製造する。Next, compound (2) is catalytically reduced to produce (2).

この工程は脱臭素の常法であり、メタノール中パラジウ
ム炭素を用いる接触還元が好適である。
This step is a conventional method for debromination, and catalytic reduction using palladium on carbon in methanol is preferred.

後は、■から水酸基をアセチル化(例えば無水酢酸−ピ
リジンを用いる方法)で保護して■を得、アミン基をメ
チル化(例えば水素化ナトリウム−ヨウ化メチルを用い
る方法)してXを得、所望により脱保護〔脱ホルミル化
〕して、Xを得る。
Next, protect the hydroxyl group from ■ by acetylation (for example, using acetic anhydride-pyridine) to obtain ■, and methylate the amine group (for example, using sodium hydride-methyl iodide) to obtain X. , optionally deprotected (deformylated) to obtain X.

本発明の化合物は、既述のように、天然物である前記一
般式(1)で表わされる化合物の合成中間体として有用
である。
As mentioned above, the compound of the present invention is useful as a synthetic intermediate for the compound represented by the general formula (1), which is a natural product.

該抗腫瘍物質を製造するためには、例えばペプチド合成
方法の常法を用いてN−保護N、O−ジメチルチロシン
にL−アラニンメチルエステルを化合させ、アミノ基の
保護基を除去してL−アラニンを化合させ、更にアミノ
基にD−アラニンを化合させてテトラペプチドを製造し
たのちX化合物のアミン基と化合させ、次いで閉環する
。この方法によれば従来、抽出のみに依存していた抗腫
瘍性物質を合成によって効率的に製造することができる
In order to produce the antitumor substance, for example, L-alanine methyl ester is combined with N-protected N,O-dimethyltyrosine using a conventional method of peptide synthesis, and the protecting group of the amino group is removed to form L. -Alanine is combined with D-alanine, and then the amino group is combined with D-alanine to produce a tetrapeptide, which is then combined with the amine group of compound X, and then the ring is closed. According to this method, antitumor substances, which conventionally relied only on extraction, can be efficiently produced by synthesis.

〔実施例〕〔Example〕

以下、本発明を参考例及び実施例によシ更に具体的に説
明するが、本発明はこれら実施例に限定されない。
Hereinafter, the present invention will be explained in more detail with reference to Reference Examples and Examples, but the present invention is not limited to these Examples.

なお、分子量は質量分析計による測定によつ  ′て求
めた。
The molecular weight was determined by measurement using a mass spectrometer.

参考例1 チロシン100fを水冷下メタノール100tnt五2
規定塩化水素−メタノール600−に溶解し、2,2−
ジメトキシプロパン25−を加えた。これを4℃に12
時間保ち、次いで45℃で2時間反応させたのち離線し
、残渣をメタノール・エーテルから再結晶し90?を得
、更に母液から25.79の無色針状晶の(II)化合
物を得た。融点184〜185℃ 参考例2 C!0OOH。
Reference example 1 100f of tyrosine was mixed with 100tnt of methanol under water cooling.
Dissolved in normal hydrogen chloride-methanol 600-, 2,2-
25-dimethoxypropane was added. Heat this to 4℃ for 12
After holding the reaction for 2 hours at 45°C, the wire was separated, and the residue was recrystallized from methanol/ether at 90°C. Further, 25.79 colorless needle crystals of compound (II) were obtained from the mother liquor. Melting point 184-185°C Reference example 2 C! 0OOH.

(ff)化合物95.5 If少量のメタノールに溶解
し、過剰の炭酸水素すl−IJウム水溶液と加え、発泡
が止ってから減圧濃縮し、ベンゼンで共沸させた。残渣
を熱酢酸エチルで繰返し抽出し、溶液を減圧濃縮したの
ち、残渣を酢酸エテル−ヘキサンから再結晶して遊離ア
ミンを71.8 fの無色プリズム晶として得た。融点
135〜136 ℃ 得られた遊離アミン509を氷冷下ぎ酸320+dK溶
解し、無水酢酸110rntを1時間で滴下し、室温で
1時間反応させたのち、30℃で減圧濃縮し、トルエン
共沸を繰返した。油状残渣分メタノール・エーテルから
結晶化し、16.912を得母液分濃縮し、残渣をメタ
ノール10〇−に溶解したのち、炭酸カリウム5.2F
を加え、0℃で25分反応させた。反応液を濾過ののち
濃縮しメタノール−エーテルから再結晶して更に141
9の(I[l)化合物を得た。融点142〜142.5
  ℃ 参考例3 COOOH。
(ff) Compound 95.5 If was dissolved in a small amount of methanol and added with an excess sodium bicarbonate aqueous solution. After bubbling stopped, the mixture was concentrated under reduced pressure and azeotroped with benzene. The residue was extracted repeatedly with hot ethyl acetate, the solution was concentrated under reduced pressure, and then the residue was recrystallized from ethyl acetate-hexane to obtain the free amine as colorless prisms of 71.8 f. Melting point: 135-136°C The obtained free amine 509 was dissolved in 320 + dK of formic acid under ice-cooling, 110rnt of acetic anhydride was added dropwise over 1 hour, the reaction was allowed to proceed at room temperature for 1 hour, and the mixture was concentrated under reduced pressure at 30°C, followed by toluene azeotroping. repeated. The oily residue was crystallized from methanol/ether to obtain 16.912, and the mother liquor was concentrated. The residue was dissolved in 100 methanol, and 5.2F potassium carbonate was obtained.
was added and reacted at 0°C for 25 minutes. The reaction solution was filtered, concentrated, and recrystallized from methanol-ether to give 141
9 (I[l) compounds were obtained. Melting point 142-142.5
℃ Reference Example 3 COOOH.

0HOHN I)4qH r CIV) (II)化合物10fをテトラヒドロフラン20〇−に
溶解し、水冷下に酢酸ナトリウム五72を懸濁させた。
0HOHN I) 4qH r CIV) (II) Compound 10f was dissolved in 200% of tetrahydrofuran, and 572% of sodium acetate was suspended under water cooling.

この液に臭素4.59 rntを5分間で滴下してから
30分反応させ、更に室温で1時間反応させた。反応液
を濾過して、酢酸エテル−水(少量のチオ硫酸ナトリウ
ムを含む)で抽出し、飽和食塩水で洗浄ののち硫酸ナト
リウムで乾燥し、減圧下Kmmした。生じた結晶性残渣
を酢酸エテル−ヘキサンから再結晶し、1a02の無色
針状晶のCF/)化合物を得た。融点16S5〜165
 ℃ 参考例4 aooc馬 H!N法H曙ct r CIV−a) (IV)化合物5.02を2規定塩化水素−メタノール
20−に溶解し、加熱還流下25分反応させたのちam
L、メタノールと共沸を繰返した。
To this solution, 4.59 rnt of bromine was added dropwise over 5 minutes, and the mixture was reacted for 30 minutes, and further reacted for 1 hour at room temperature. The reaction solution was filtered, extracted with ethyl acetate-water (containing a small amount of sodium thiosulfate), washed with saturated brine, dried over sodium sulfate, and concentrated under reduced pressure. The resulting crystalline residue was recrystallized from ethyl acetate-hexane to obtain CF/) compound 1a02 in the form of colorless needles. Melting point 16S5~165
℃ Reference example 4 aooc horse H! N method H dawn ct r CIV-a) (IV) Compound 5.02 was dissolved in 2N hydrogen chloride-methanol 20- and reacted for 25 minutes under heating reflux.
Repeated azeotropy with L and methanol.

残渣をメタノール−エーテルかう再結晶して5.02の
無色針状晶のIJV−a)化合物を得た。融点119〜
120 ℃ 0OH OHCtHNしかくH r C■−b) CF/)化合物5.、orをジオキサン(s ay)−
メタノール(5−)の混合溶媒に溶解し、1規定水酸化
ナトリウム水溶液26−を加え、室温で20分反応させ
た。反応溶液にアンバーライトエR−120(ローム 
アンド ハース社製)(H生型)の過剰量を加え、かく
はんののち濾過した。F液にエタノールを加えてから濃
縮を繰返し残渣を少量のエタノールに溶解したのちエー
テルを加えると4.714Fの無定形固体として(F/
−1))化合物を得た。
The residue was recrystallized from methanol-ether to obtain 5.02 colorless needles of compound IJV-a). Melting point 119~
120°C 0OH OHCtHN H r C■-b) CF/) Compound 5. , or is dioxane (say)-
The mixture was dissolved in a mixed solvent of methanol (5-), 1N aqueous sodium hydroxide solution (26-) was added, and the mixture was reacted at room temperature for 20 minutes. Add Amberlite E R-120 (ROHM) to the reaction solution.
To the mixture was added an excess amount of H-green (manufactured by J.D. & Haas), stirred, and then filtered. Add ethanol to solution F, repeat the concentration, dissolve the residue in a small amount of ethanol, and add ether to form an amorphous solid of 4.714F (F/
-1)) Compound was obtained.

工ull  ヌジ田−ルー−”  :  3350,3
200br、1755,1670br。
3350,3
200br, 1755, 1670br.

ax 1555.153O NMR(アセトン−4)δ :2.9〜五4(2H,コ
ンプレックス)、5.82(IH,brdd、J−7,
515Hz)、7.45(2Js)、a20(IH,s
)参考例5 (V) (rv−b)化合物五999を塩化メチレン10〇−に
懸濁させ、2.2’−ジピリジルジスルフィド2−88
t、N−ヒドロキシコハク酸イミド2.86tttnt
た。次いでトリフェニルホスフィン五432を加え反応
液が黄色澄明となってからトリエチルアミン1.52m
と(IV−a)化合物4,242を加え、室温で18時
間反応させた。生じた沈殿を戸取し、酢酸エチル、2%
酢酸水溶液、飽和炭酸水素ナトリウム水溶液そして水で
洗浄したのち、テトラヒドロフラン−メタノール(1:
1)から再結晶し、4.50fの無色微細結晶の(V)
化合物を得た。
ax 1555.153O NMR (acetone-4) δ: 2.9-54 (2H, complex), 5.82 (IH, brdd, J-7,
515Hz), 7.45 (2Js), a20 (IH,s
) Reference Example 5 (V) (rv-b) Compound 5999 was suspended in 100-methylene chloride, and 2,2'-dipyridyl disulfide 2-88
t,N-hydroxysuccinimide 2.86tttnt
Ta. Next, 1.52 m of triphenylphosphine was added and the reaction mixture became clear yellow.
and (IV-a) Compound 4,242 were added and reacted at room temperature for 18 hours. The resulting precipitate was collected and diluted with ethyl acetate, 2%
After washing with acetic acid aqueous solution, saturated sodium bicarbonate aqueous solution and water, tetrahydrofuran-methanol (1:
Recrystallized from 1), colorless fine crystals of 4.50 f (V)
The compound was obtained.

更に、F液と洗液を合わせ酢酸エチル−水、2%酢酸水
溶液、飽和炭酸水素ナトリウム水溶液及び飽和食塩水で
分配し、硫酸ナトリウムで乾燥して減圧下に濃縮した。
Furthermore, the F solution and the washing liquid were combined and partitioned between ethyl acetate-water, 2% acetic acid aqueous solution, saturated sodium bicarbonate aqueous solution, and saturated brine, dried over sodium sulfate, and concentrated under reduced pressure.

生じた残渣をクロロホルムに溶解して放置し、析出した
沈殿を枦取し再結晶して680m9の(V)化合物を得
た。
The resulting residue was dissolved in chloroform and left to stand, and the deposited precipitate was collected and recrystallized to obtain 680 m9 of compound (V).

融点254〜257℃(分解) 実施例1 〔■〕 (V)化合物951■をジメチルホルムアミド20−に
溶解し、メタノール600−を加え水冷下に硝酸タリウ
ムt 84 tを一時に加え30分水冷を保ったのち、
2℃で18時間反応させた。反応液を30℃以下で約2
00wtまで濃縮し、残渣を約11の酢酸エチルに注い
だ。この溶液を2%酢酸水溶液、次いで飽和炭酸水素ナ
トリウム水溶液で洗浄し、生じた沈殿をセライトテ過し
、F液を飽和食塩水で洗浄した。酢酸水層は酢酸エチル
で抽出し、飽和炭酸水素ナトリウム水溶液、飽和食塩水
で分配した。また、炭酸水素ナトリウム水層についても
酢酸エテルで抽出し、飽和食塩水で洗浄した。
Melting point: 254-257°C (decomposition) Example 1 [■] (V) Compound 951■ was dissolved in dimethylformamide 20-20-, methanol 600- was added, and thallium nitrate t84 t was added at once while cooling with water for 30 minutes. After keeping it,
The reaction was carried out at 2°C for 18 hours. The reaction solution was heated at 30°C or less for about 2
00 wt and the residue was poured into ca. 11 ml of ethyl acetate. This solution was washed with a 2% acetic acid aqueous solution and then with a saturated sodium bicarbonate aqueous solution, the resulting precipitate was filtered through Celite, and the F solution was washed with a saturated saline solution. The acetic acid aqueous layer was extracted with ethyl acetate, and partitioned between a saturated aqueous sodium bicarbonate solution and saturated brine. The aqueous sodium bicarbonate layer was also extracted with ethyl acetate and washed with saturated brine.

すべての有機層を合わせ、硫酸ナトリウムで乾燥ののち
減圧下に濃縮し、得られた褐色油状残渣をPTLC(展
開溶媒クロロホルム/メタノール 18:1)で展開し
て、クロロホルム/メタノール 8:1の溶媒系におい
てRfα61に相当する部分を分取し、34.8ダの無
色油状の(Vl)化合物を得た。
All the organic layers were combined, dried over sodium sulfate, and then concentrated under reduced pressure. The resulting brown oily residue was developed with PTLC (developing solvent: chloroform/methanol 18:1) to obtain a solvent of chloroform/methanol (8:1). A portion corresponding to Rfα61 in the system was fractionated to obtain 34.8 Da of colorless oily compound (Vl).

〔■〕化合物 〔α〕管+894°(C!= 1.22 、0HCl、
 )元素分析 計算値011 HI@ % Oy Br
g (M”)分子量649.8721実測値分子量64
9.B7A9 工Rシフイア〜−1:  3370,1735,168
5,1655θh、1600゜ax 55O NMR(ODO/、)δ :2.5〜17(2H,コン
プレックス)、 五20(34θ)、五3〜五7(2H
,コンプレックス)、 xao(3H,s)、4.28
([、d、、T=3Bの、 4.6〜5.1(2H,1
ンブνツクス)、&75(1H,br、d、J=12H
2)、6.85(1a、a、J=3Hz)、7.20(
1H,s)、7.25(1a、a、溶媒のシグナルと重
複)、7.68(1H,br。
[■] Compound [α] tube +894° (C!= 1.22, 0HCl,
) Elemental analysis Calculated value 011 HI@% Oy Br
g (M”) Molecular weight 649.8721 Actual molecular weight 64
9. B7A9 Engineering R Shifia ~-1: 3370, 1735, 168
5,1655θh, 1600°ax 55O NMR (ODO/,) δ: 2.5-17 (2H, complex), 520 (34θ), 53-57 (2H
, complex), xao(3H,s), 4.28
([,d,,T=3B,4.6~5.1(2H,1
), &75(1H, br, d, J=12H
2), 6.85 (1a, a, J=3Hz), 7.20 (
1H, s), 7.25 (1a, a, overlapping with solvent signal), 7.68 (1H, br.

d、J=12Hz)、 a32 (IH,s)更に、R
f(lL37〜[159部分より543■のアセトン可
溶、酢酸エチル、クロロホルム、メタノール等に難溶の
無定形固体を含む褐色の油状混合物〔■−巴〕を得た。
d, J=12Hz), a32 (IH, s) Furthermore, R
A brown oily mixture [■-Tomoe] containing an amorphous solid soluble in acetone and sparingly soluble in ethyl acetate, chloroform, methanol, etc. was obtained from the 159 parts.

〔■〕[■]

(Vl)化合物25■をテトラヒドロフラン2−に溶解
し、水冷下に3規定塩酸で2分間洗浄、次いで蒸留水で
上澄みが中性になるまで洗浄したのち、エタノール、エ
ーテルで洗浄し、減圧下に乾燥させた亜鉛末50m9を
懸濁させた。激しくかくはんしながら酢酸[11−を滴
下し、12分後、再び酢酸(LO5−を滴下し、更に2
5分間反応させた。生じた不溶物を濾過ののち酢酸エチ
ル−精嚢塩水で分配し、有機層を硫酸ナトリウムで乾燥
させ濃縮した。これをPTLC(展開溶媒クロロホルム
/メタノール 1[]:1)で精製し、22.8■の無
色油状の〔■〕化合物を得た。
(Vl) Compound 25■ was dissolved in tetrahydrofuran 2-, washed with 3N hydrochloric acid for 2 minutes while cooling with water, then washed with distilled water until the supernatant became neutral, washed with ethanol and ether, and then washed under reduced pressure. 50 m9 of dried zinc dust was suspended. While stirring vigorously, acetic acid [11-] was added dropwise, and after 12 minutes, acetic acid (LO5-) was added dropwise again.
The reaction was allowed to proceed for 5 minutes. The resulting insoluble matter was filtered and partitioned between ethyl acetate and seminal vesicle brine, and the organic layer was dried over sodium sulfate and concentrated. This was purified by PTLC (developing solvent chloroform/methanol 1[]:1) to obtain 22.8 ㎡ of a colorless oily [■] compound.

更に混合物(vl−a) s a s In9も同様に
処理して29.7■の〔■〕化合物を得た。
Further, the mixture (vl-a) sas In9 was treated in the same manner to obtain 29.7■ [■] compound.

〔α〕管+72.7°(0=1.14 0HO/、 )
元素分析 計算値 Os Hsq N! Oa Brs
(M”)分子量619.8615実測値 分子量619
.8614 工Rシフイル”  ylH−”  :  3400,1
735,1690sh、1680,1660゜ax j580.1505 NMR(CD(!ls)δ :   2.3〜2.6 
(2H,コンフレックス) 、五3〜16(2H。
[α] Tube +72.7° (0=1.14 0HO/, )
Elemental analysis Calculated value Os Hsq N! Oa Brs.
(M”) Molecular weight 619.8615 Actual value Molecular weight 619
.. 8614 Engineering R Shifil "ylH-": 3400,1
735,1690sh, 1680,1660゜ax j580.1505 NMR (CD(!ls)δ: 2.3-2.6
(2H, Conflex), 53-16 (2H.

コンフレックス)、 3.75(3H,8)、 a、4
〜5.1(4H,コンフレックス)、5.10(IH,
d、J=IH2)、5.15(1H,br、d、、T=
9Hz)、6.90(1a、a、、y=1Hz)、6.
95(IH,br、d、J=9H2)、7.25(IH
Conflex), 3.75 (3H, 8), a, 4
~5.1 (4H, Conflex), 5.10 (IH,
d, J=IH2), 5.15(1H,br,d,,T=
9Hz), 6.90 (1a, a, y=1Hz), 6.
95 (IH, br, d, J = 9H2), 7.25 (IH
.

溶媒のシグナルと重複)、7.68(IH,d、J=I
H2)、s、1y(IHl 8) 実施例2 〔■〕化合物407mgを酢酸ナトリウム30■を含む
メタノール15−に溶解し、触媒量の55パラジウム/
カーボンを加えたのち、系内を水素で置換し、室温で一
晩接触還元を行った。
overlap with solvent signal), 7.68 (IH, d, J=I
H2), s, 1y (IHl 8) Example 2 [■] 407 mg of the compound was dissolved in methanol 15 containing 30 μ of sodium acetate, and a catalytic amount of 55 palladium/
After adding carbon, the atmosphere in the system was replaced with hydrogen, and catalytic reduction was performed overnight at room temperature.

反応液を濾過して、F液を酢酸エチル−2%酢酸水溶液
、飽和炭酸水素ナトリウム水溶液で分配し、飽和食塩水
で洗浄したのち、硫酸ナトリウムで乾燥し、濃縮した。
The reaction solution was filtered, and solution F was partitioned between an ethyl acetate-2% aqueous acetic acid solution and a saturated aqueous sodium bicarbonate solution, washed with saturated brine, dried over sodium sulfate, and concentrated.

生じた残渣をPTLC!(J[溶媒クロロホルム/メタ
ノール 15:1)で展開分取し、2L4Wの無色プリ
ズム状結晶の〔■〕化合物を得た。
PTLC the resulting residue! The mixture was developed and fractionated using (J [solvent chloroform/methanol 15:1)] to obtain a colorless prismatic crystal [■] compound of 2L4W.

一部を分析用サンプルとしてアセトンから再結晶した。A portion was recrystallized from acetone as a sample for analysis.

融点156〜158℃ 〔α〕1+137.6° (0=(L91、メタノール
)実施例3 〔■〕化合物1a2ダを無水酢酸−ビリジン(各1−)
に溶解し、室温で8時間反応させ、これをトルエンで共
沸処理した。生じた残渣をPTLC(展開溶媒クロロホ
ルム−メタノール15:1)で精製し、193〜の無色
油状の〔幻化合物を得た。
Melting point 156-158°C [α] 1+137.6° (0 = (L91, methanol) Example 3 [■] Compound 1a2 da was dissolved in acetic anhydride-pyridine (each 1-)
The mixture was dissolved in water, reacted at room temperature for 8 hours, and azeotropically treated with toluene. The resulting residue was purified by PTLC (developing solvent chloroform-methanol 15:1) to obtain colorless oily [phantom compound] 193.

〔α〕習+84°(Cコα84、aHctm)元素分析
 計算値 C□4.馬OF (M+)分子量426.1
425実測値 分子j1426,1422 フィルム  −l 。
[α] +84° (C α84, aHctm) Elemental analysis Calculated value C□4. Horse OF (M+) molecular weight 426.1
425 Actual value Molecule j1426,1422 Film -l.

工Rν 、aX、  、 3400.1745tlr、
1670,1590.1505実施例4 (IX)化合物17.3■を波付フラスコに入れ、ベン
ゼンにて共沸処理を2回行った。次に系内をフルボン算
囲気としたのちジメチルホルムアミド3−に溶解し、水
冷下、ヨウ化メチル50μl を加え、次いで水素化ナ
トリウム(鉱油中、60% &1■)を激しくかくはん
しながら加えて25分間反応させた。反応液に酢酸1−
を加えて反応を停止させ、発泡が完全に終了したのち、
酢酸エチル−2%酢酸水溶液、飽和炭酸水素す) IJ
ウム水溶液、飽和食塩水で分配し、有機層を硫酸ナトリ
ウムで乾燥させた。濃縮残渣をPTLO(展開溶媒クロ
ロホルム−メタノール 19:1)を用いてRfo、4
6とRfo、41の無色油状物を各(X−a)化合物(
& Om9 ) 、(X−b)化合物(7,3q)とし
て分取した。
Engineering Rν, aX, , 3400.1745tlr,
1670, 1590.1505 Example 4 (IX) Compound 17.3■ was placed in a corrugated flask and azeotropically treated with benzene twice. Next, the system was made to have a fulvone atmosphere, then dissolved in dimethylformamide 3-, and while cooling with water, 50 μl of methyl iodide was added, and then sodium hydride (60% in mineral oil, 1 μl) was added with vigorous stirring. Allowed to react for minutes. Acetic acid 1-
was added to stop the reaction, and after foaming was completed,
Ethyl acetate - 2% acetic acid aqueous solution, saturated hydrogen carbonate) IJ
The mixture was partitioned between aqueous sodium chloride solution and saturated brine, and the organic layer was dried over sodium sulfate. The concentrated residue was purified by Rfo using PTLO (developing solvent chloroform-methanol 19:1).
6 and Rfo, the colorless oil of 41 was added to each (X-a) compound (
&Om9), (Xb) was fractionated as compound (7,3q).

これらの化合物はどちらも室温で一部異性化するため、
純粋に得ることはできなかった。
Both of these compounds are partially isomerized at room temperature, so
I couldn't get it purely.

(X−a)化合物 NMR(cDcr、)δ:  2.3?(3H,s)、
2.6〜五7([、コンプレックス)、  2.71,
2.75(トータル 3H,a)、 2.89,2.9
4()→ル3H,s)、五72,176(トーゴタk 
 5H,B)、X76(3H,a)、4.25(1H,
d、:r=1Hz)、4.41〜s、1(aa、コンフ
レックス)、6.6〜7.6(7H,コl−クス、溶媒
のシグナルと重複)、7.80.aoo()−、タル 
jH,s) 、(X−1))化合物 NMR(ODO/、)  δ :  2.35(3H,
8)、  2.73,2.79()=タル 3H。
(X-a) Compound NMR (cDcr,) δ: 2.3? (3H,s),
2.6-57 ([, complex), 2.71,
2.75 (total 3H, a), 2.89, 2.9
4() → Ru 3H, s), 572,176 (Togota k
5H, B), X76 (3H, a), 4.25 (1H,
d, :r=1Hz), 4.41-s, 1 (aa, conflux), 6.6-7.6 (7H, cox, overlapping with solvent signal), 7.80. aoo()-, tal
jH,s), (X-1)) Compound NMR (ODO/,) δ: 2.35 (3H,
8), 2.73, 2.79 () = Tal 3H.

a)、 2.87,2.90()−タル 5H,a)、
16〜!L7 (AH,−コンプレックス)、五75(
3H,θ)、 五73.五75(トータル 3H,s)
、4.7〜a 1(2Htコンブνツクス)、 5.0
8(1B、’br、g)、6.5〜7.7 (7H。
a), 2.87, 2.90 ()-tal 5H, a),
16~! L7 (AH, - complex), 575 (
3H, θ), 573. 575 (total 3H, s)
, 4.7~a 1 (2Ht Kombuchus), 5.0
8 (1B,'br,g), 6.5-7.7 (7H.

溶媒のシグナルと重複)、aoo、 A12()−ルI
H,8) 平衡混合物 工Rシ7コS譚−” : 1760sh、 1740 
、1660 、1650゜1590 、1500 元素分析 計算値c、4Tl@、 01馬(M+)分子
量454.1738実測値 454.1730 実施例5 (X−a) 、 (X−1))の平衡混合物y、 a 
qK 2 規定塩化水素−メタノール1−を加え4時間
30分加熱還流したのち、減圧下に濃縮、メタノールを
加えて濃縮することを数回繰返した。残渣をPTLO(
、llJ溶媒クロロホルム−メタノール8:1)を用い
テfft ’Aし、Rfrl、A2とRfl153の無
色半結晶固体を平衡混合物(i71rI9)として得た
overlap with solvent signal), aoo, A12()-le I
H, 8) Equilibrium Mixture Engineering R Shi7ko S Tan-”: 1760sh, 1740
, 1660 , 1650° 1590 , 1500 Elemental analysis Calculated value c, 4Tl@, 01 Horse (M+) Molecular weight 454.1738 Actual value 454.1730 Example 5 Equilibrium mixture y of (X-a) and (X-1)) , a
After adding qK 2 normal hydrogen chloride-methanol 1- and heating under reflux for 4 hours and 30 minutes, concentration under reduced pressure and addition of methanol and concentration were repeated several times. PTLO the residue (
, llJ solvent chloroform-methanol 8:1) to obtain a colorless semi-crystalline solid of Rfrl, A2 and Rfl153 as an equilibrium mixture (i71rI9).

工’flyフイ” cm−”  :  210(1−3
700br、1745,1660  。
Engineering 'fly height cm-': 210 (1-3
700br, 1745,1660.

ax 1595、1525 、1505 NMR(OニーOD) δ :  2..60  、 
2.63  () −ル 3H,s)、 z94 。
ax 1595, 1525, 1505 NMR (O knee OD) δ: 2. .. 60,
2.63 ()-ru 3H,s), z94.

五13(トータル 3H,日) 、2.60〜4.0(
コンプレックス、 溶媒のシグナルと重複)、4.35
 、5.20(トタルIH,br。
513 (total 3H, day), 2.60-4.0 (
complex, overlap with solvent signal), 4.35
, 5.20 (Total IH, br.

8)、 6.5〜7.8 (7H,コンプレックス)元
素分析 計算値 On H*+ Os N* (M”−
HC/)  分子量384゜1684 実測値 3134.1700 〔発明の効果〕 以上説明したように、本発明によれば、薬効ある化合物
の合成中間体として有用な化合物及びその製造方法が提
供される。
8), 6.5-7.8 (7H, complex) Elemental analysis Calculated value On H**+ Os N* (M"-
HC/) Molecular weight: 384°1684 Actual value: 3134.1700 [Effects of the Invention] As explained above, according to the present invention, a compound useful as a synthetic intermediate for medicinal compounds and a method for producing the same are provided.

Claims (1)

【特許請求の範囲】 1、下記一般式 ▲数式、化学式、表等があります▼ (式中、R_1は水素又はホルミル基、R_2は水素又
はメチル基、R_3は水素又はアセチル基、R_4は低
級アルキル基、R_5は水素又はメチル基、Xは水素又
は臭素を示す)で表わされることを特徴とする環状ビフ
ェニルエーテル化合物。 2、下記一般式 ▲数式、化学式、表等があります▼ (式中、R_1は水素又はホルミル基、R_2は水素又
はメチル基、R_3は水素又はアセチル基、R_4は低
級アルキル基、R_5は水素又はメチル基を示す)で表
わされる化合物を接触還元することを特徴とする下記一
般式 ▲数式、化学式、表等があります▼ (式中R_1〜R_5は前記のとおりである)で表わさ
れる環状ビフェニルエーテル化合物の製造方法。 3、下記一般式 ▲数式、化学式、表等があります▼ (式中、R_4は低級アルキル基を示す)で表わされる
化合物を、メタノール含有溶媒中、タリウム(III)塩
で処理して、下記一般式 ▲数式、化学式、表等があります▼ (式中R_4は前記のとおりである)で表わされるジエ
ノン化合物を得、これを亜鉛還元して下記一般式 ▲数式、化学式、表等があります▼ (式中R_4は前記のとおりである)で表わされる化合
物を得、これを接触還元し、次いでアセチル化及び/又
はメチル化し、更に所望により保護基を除去することを
特徴とする下記一般式 ▲数式、化学式、表等があります▼ (式中、R_1は水素又はホルミル基、R_2は水素又
はメチル基、R_3は水素又はアセチル基、R_4は前
記のとおり、R_5は水素又はメチル基を示すが、R_
2、R_3及びR_5のうち少なくとも1つは水素以外
の基を示す)で表わされる環状ビフェニルエーテル化合
物の製造方法。
[Claims] 1. The following general formula ▲ Numerical formula, chemical formula, table, etc. ▼ (In the formula, R_1 is hydrogen or formyl group, R_2 is hydrogen or methyl group, R_3 is hydrogen or acetyl group, R_4 is lower alkyl A cyclic biphenyl ether compound, characterized in that R_5 is hydrogen or a methyl group, and X is hydrogen or bromine. 2. The following general formula ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ (In the formula, R_1 is hydrogen or formyl group, R_2 is hydrogen or methyl group, R_3 is hydrogen or acetyl group, R_4 is lower alkyl group, R_5 is hydrogen or Cyclic biphenyl ether represented by the following general formula ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ (wherein R_1 to R_5 are as above), which is characterized by catalytic reduction of a compound represented by (representing a methyl group) Method of manufacturing the compound. 3. A compound represented by the following general formula ▲ There are mathematical formulas, chemical formulas, tables, etc. A dienone compound represented by the formula ▲ has mathematical formulas, chemical formulas, tables, etc. ▼ (in the formula, R_4 is as above), and this is reduced with zinc to form the following general formula ▲ mathematical formulas, chemical formulas, tables, etc. ▼ ( The following general formula ▲ is characterized by obtaining a compound represented by the formula (in which R_4 is as described above), subjecting it to catalytic reduction, then acetylating and/or methylating it, and further removing the protecting group if desired. , chemical formulas, tables, etc.
2, at least one of R_3 and R_5 represents a group other than hydrogen).
JP60137033A 1985-06-25 1985-06-25 Cyclic biphenyl ether compound and method for producing the same Expired - Lifetime JPH0662670B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP60137033A JPH0662670B2 (en) 1985-06-25 1985-06-25 Cyclic biphenyl ether compound and method for producing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60137033A JPH0662670B2 (en) 1985-06-25 1985-06-25 Cyclic biphenyl ether compound and method for producing the same

Publications (2)

Publication Number Publication Date
JPS62497A true JPS62497A (en) 1987-01-06
JPH0662670B2 JPH0662670B2 (en) 1994-08-17

Family

ID=15189276

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60137033A Expired - Lifetime JPH0662670B2 (en) 1985-06-25 1985-06-25 Cyclic biphenyl ether compound and method for producing the same

Country Status (1)

Country Link
JP (1) JPH0662670B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6588451B2 (en) 2000-03-08 2003-07-08 Kawasaki Jukogyo Kabushiki Kaisha Holding structure for holding device on fuel tank

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6588451B2 (en) 2000-03-08 2003-07-08 Kawasaki Jukogyo Kabushiki Kaisha Holding structure for holding device on fuel tank

Also Published As

Publication number Publication date
JPH0662670B2 (en) 1994-08-17

Similar Documents

Publication Publication Date Title
JPS6055506B2 (en) Novel ω-aminocarboxylic acid amide and its production method
JPH07503942A (en) Protected phosphonoalkylphenylalanine compounds for use in peptide synthesis
JPS5885889A (en) Novel deazapurine derivative
US6123917A (en) Method for making cocaine receptor binding ligands and intermediates therefor
GB1569341A (en) Process for the manufacture of indole derivates
JPS62497A (en) Cyclic biphenyl ether compound and production thereof
AU661475B2 (en) N-((4,5-dihydroxy- and 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracene-yl) carbonyl)amino acids useful in the therapy of osteoarticular affections
JPS5936914B2 (en) Cephalosporin analogs
Archer et al. The preparation of some iodinated phenyl‐and pvridylalkanoic acids
JPS6012339B2 (en) Optically active mandelic acid/phenylglycinol salt and its production method
JP2868024B2 (en) Improved process for producing ketone compounds
JPH05500214A (en) Novel synthesis method for tertiary alkyl esters
JPS6045588A (en) Novel oligomannoside and its preparation
JPS6311359B2 (en)
SE441355B (en) ADDUCTS OF 1,8-DIHYDROXI-9 ANTRON, PROCEDURES FOR PREPARING THEREOF AND COMPOSITIONS IN PARTICULAR WITH EFFECT ON PSORIASIS AND VARIETIES
JPS6033120B2 (en) Novel muramyl dipeptide derivative
KR800000540B1 (en) Process for the peparation of amin-pheny-ethanolamines
JPS6312879B2 (en)
JPS6328075B2 (en)
Hurd et al. Cyclic Acetals Related to Ethylacetonylbarbituric Acid
JPH0745501B2 (en) Novel cyclic dipeptide compound
JPS6289659A (en) Anisomycin derivative and production thereof
JPS58135890A (en) Production of alpha-substituted ureidobenzylpenicillanic acid
JPH02502381A (en) 1-Trifluoromethyltetralin derivatives, their synthesis method and use for the synthesis of compounds with therapeutic effects
JPS6039062B2 (en) Process for producing arylacetic acid and its ester